0 items USD 0.00Search
Your search for "delveinsight cervical cancer global api manufacturers marketed phase iii drugs landscape 2016" gave back 321320 results.
The global Nedaplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The “Nedaplatin API Industry Forecast” looks at past sales and reviews total world Nedaplatin API sales in 2022, providing a comprehensive analysis...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Nedaplatin API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Nedaplatin API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of %...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
HJ Research delivers in-depth insights on the global Paclitaxel API market in its upcoming report titled, Global Paclitaxel API Market Report 2015-...
Catalog:
HJResearch
February 2022
Price: USD 3,200.00
Summary Cancer Biomarker market research report provides the newest industry data and industry future trends, allowing you to identify the products...
Catalog:
ICRW
December 2020
Price: USD 2,960.00
Summary Paclitaxel market research report provides the newest industry data and industry future trends, allowing you to identify the products and end...
Catalog:
ICRW
March 2021
Price: USD 2,960.00
Vinblastinesulphate (CAS 143-67-9) Market will register a 1.6% CAGR in terms of revenue, reach US$ 21 million by 2023, from US$ 19 million in 2017...
Catalog:
MRRPB2
September 2018
Price: USD 4,660.00
Pazopanib is an anticancer medication that belongs to the class of drugs known as kinase inhibitors. It is primarily used for the treatment of...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Platinum-based Anticancer APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Rucaparib API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
10-Deacetylbaccatin III market will register a 4.3% CAGR in terms of revenue, reach US$ 74 million by 2023, from US$ 58 million in 2017. This report...
Catalog:
MRRPB2
September 2018
Price: USD 4,660.00
The “Protein Bound Paclitaxel (Abraxane) Industry Forecast” looks at past sales and reviews total world Protein Bound Paclitaxel (Abraxane) sales in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
